SCHEMBL14708702

SCHEMBL14708702

CCN1CCN(c2ccc(S(=O)(=O)Nc3cc(O)c(OC)c(OC)c3)cc2)C1=O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 6/20 0.52
HTT P42858 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
GHSR Q92847 1/20 0.40
HIF1A Q16665 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 1/20 0.38
LMNA P02545 2/20 0.38
THRB P10828 2/20 0.38
ALOX12 P18054 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
ALOX15 P16050 1/20 0.38
MAPK1 P28482 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14119673 0.85 CYP1A1 (0.70) CYP1A1HTTSMN1; SMN2GHSRHIF1A
SCHEMBL16178221 0.83 CYP1A1 (0.71) CYP1A1HTTSMN1; SMN2GHSRL3MBTL1
SCHEMBL16178226 0.83 CYP1A1 (0.72) CYP1A1HTTSMN1; SMN2GHSRHIF1A
SCHEMBL14217387 0.82 CYP1A1 (0.63) CYP1A1HTTSMN1; SMN2GHSRHIF1A
SCHEMBL16186796 0.80 CYP1A1 (0.64) CYP1A1HTTSMN1; SMN2GHSRHIF1A
SCHEMBL16186811 0.80 CYP1A1 (0.65) CYP1A1HTTSMN1; SMN2GHSRHIF1A
SCHEMBL14119726 0.75 CYP1A1 (0.63) CYP1A1HTTSMN1; SMN2HIF1ANPSR1
SCHEMBL2303592 0.73 HTT (0.52) CYP1A1HTTSMN1; SMN2GHSRHIF1A
SCHEMBL13150525 0.73 CYP1A1 (0.47) CYP1A1HTTSMN1; SMN2LMNA
SCHEMBL14217285 0.72 HTT (0.50) HTTSMN1; SMN2GHSRHIF1ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013023274-A1 SUBSTITUTED 2-IMIDAZOLIDINONES AND 2-IMIDAZOLONES AND THEIR USE IN THE TREATMENT OF CANCER UNIVERSITE LAVAL (CA) 2013-02-21 WO disclosed